Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37 results about "Retina Layer" patented technology

The tissue that constitutes the retina. It is composed of the following layers: ganglion cell layer, inner limiting membrane, inner nuclear layer, inner plexiform layer, layer of the ophthalmic nerve fibers, layer of the rods and cones, neural retina, outer limiting membrane, outer nuclear layer, outer plexiform layer, and retinal pigment epithelium.

Layer segmentation method and system for retina layer and effusion area based on deep learning

The invention discloses a layer segmentation method and system for a retina layer and an effusion area based on deep learning. The method comprises the following steps: acquiring a retina OCT data setof each node area in a medical system, dividing the data set into a pre-training data set and a test data set, and randomly translating data in the pre-training data set to obtain a training data set; carrying out forward propagation on the data in the training data set sent to the segmentation network in batches according to the constructed segmentation network and the corresponding loss function to obtain a segmentation prediction graph; according to a joint loss function formula, calculating a joint loss value between the segmentation prediction graph and a standard probability graph afterone-hot coding is carried out on the expert pixel-level marking image, carrying out back propagation on the joint loss value, and obtaining a segmentation network model through iterative training ofa preset period length; and testing the segmentation network model through the test data set to verify the reliability of the segmentation network model. According to the method and system, the generalization ability and the category segmentation accuracy of the segmentation network can be improved.
Owner:SUN YAT SEN UNIV

Robot remote fixed point control method for human eye subretinal injection

The invention relates to a robot remote fixed point control method for human eye subretinal injection, which comprises the following steps of: 1, selecting a needle inserting position, and setting a motion path of a mechanical arm; 2, obtaining an injection through an injector; 3, controlling the mechanical arm to move along a set movement path, and making the tail end of the needle tip move to a turning point along the movement path; 4, using the mechanical arm to drive the tail end of the needle tip to execute RCM movement at the turning point; 5, using the mechanical arm to drive the tail end of the needle tip to continue to move to the target position of the retina layer according to the movement path set in the step 2; and 6, injecting a certain amount of injection to the target position. According to the method, in a high-precision environment with resistance, the degree of freedom of motion of the mechanical arm can be guaranteed, a control mode of precisely completing closed-loop motion can be provided, the precision limitation caused when the mechanical arm is manually operated to complete a retina injection operation is overcome, the precision is improved, the difficulty of manual operation is reduced, and unnecessary injuries are avoided.
Owner:GUANGZHOU WEIMOU MEDICAL INSTR CO LTD

Prediction method of choroidal neovascularization based on constitutive model and finite element method

The invention discloses a choroidal neovascularization growth protection method combining a constitutive model with a finite element. The method comprises the steps of image preprocessing; area division and partition, specifically including dividing an image into four areas consisting of a CNV area, an outer retina layer, an inner retina layer and a choroids layer; meshing, specifically including performing tetrahedral mesh generation on the four areas; modeling, specifically including modeling by using a hyperelastic biomechanical model and a reaction diffusion equation, and adding quality variation after choroidal neovascularization grows into an equation as a source item, thus causing a deformation gradient tensor to continuously change according to the growth of the new vessel; optimizing the model, computing the best accuracy rate, and performing parameter test; and fitting a parameter curve according to a parameter predicted at each time point, and predicting the growth parameter of the last time point to acquire a prediction result. According to the method provided by the invention, the biomechanical model can be built in a more flexible and personalized mode, the model assumes that organization is orthotropic, the good prediction results can be provided for non-linear large-deformation areas, and the accuracy is high.
Owner:SUZHOU BIGVISION MEDICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products